These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3530707)

  • 21. Fibrosing alveolitis and chronic liver disease.
    Turner-Warwick M
    Q J Med; 1968 Jan; 37(145):133-49. PubMed ID: 4872529
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia antigen and autoantibodies in chronic liver diseases].
    Müller R; Kalden J; Deicher H
    Verh Dtsch Ges Inn Med; 1972; 78():926-8. PubMed ID: 4665781
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoantibodies in serum and ascitic fluid in hepatic cirrhosis and their correlation with the clinical and laboratory findings.
    Mehrotra MP; Saxena KK
    J Indian Med Assoc; 1974 Apr; 62(8):270-2. PubMed ID: 4412132
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunofluorescence in liver diseases].
    Velasco M; Rodríguez A; García H; Katz R; Gazmuri R; Robles A
    Rev Med Chil; 1966 Dec; 94(12):763-9. PubMed ID: 4872110
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antiperinuclear and antikeratin antibodies in liver diseases].
    Youinou P; Miossec P; Pennec Y; Boles JM; Le Goff P; Le Menn G
    Sem Hop; 1983 Mar; 59(9):589-92. PubMed ID: 6190231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic significance of autoantibodies present in the blood of patients with liver diseases].
    Barabino A; Di Benedetto G; Indiveri F; Molinelli G; Puppo F; Soldà AM
    Arch Maragliano Patol Clin; 1974; 30(1):13-21. PubMed ID: 4480694
    [No Abstract]   [Full Text] [Related]  

  • 27. [Significance of anti-mitochondria antibodies in liver pathology and during syphilis].
    André D; Salussola D; Trepo C; Sepetjian M; Monier JC; Thivolet J
    Pathol Biol (Paris); 1973 Sep; 21(7):697-706. PubMed ID: 4584845
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of antibodies to acetaldehyde-albumin conjugates in alcoholic liver disease.
    Teare JP; Carmichael AJ; Burnett FR; Rake MO
    Alcohol Alcohol; 1993 Jan; 28(1):11-6. PubMed ID: 8471080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated rat hepatocytes as a tool for the determination of antibodies against human liver cell membrane.
    Autuori F; Capucci E; Conti Devirgiliis L; Di Giacomo C; Dini L; Marinucci G
    Biomed Pharmacother; 1983; 37(9-10):458-61. PubMed ID: 6372885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
    Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
    An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological diagnosis of evolutive liver diseases].
    Danieli G; Malini PL; Dal Monte PR; Montroni M; La Placa R
    Minerva Med; 1973 Mar; 64(13):608-12. PubMed ID: 4571922
    [No Abstract]   [Full Text] [Related]  

  • 32. LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity.
    Csepregi A; Nemesánszky E; Luettig B; Obermayer-Straub P; Manns MP
    Am J Gastroenterol; 2001 Mar; 96(3):910-1. PubMed ID: 11280576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the etiology of chronic non-alcoholic liver disease in Naples and Copenhagen.
    Del Vecchio-Blanco C; Caporaso N; Tage-Jensen U; Di Sapio M; Schlichting P
    Scand J Gastroenterol; 1984 Nov; 19(8):1081-5. PubMed ID: 6398508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenic significance of autoimmune processes in liver diseases].
    Morgunov IN; Khatuntsev VV; Bordonos VG; Mitchenko IK
    Vrach Delo; 1966 Mar; 3():7-10. PubMed ID: 5990040
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phenotype study of blood T lymphocytes in alcoholic hepatopathies].
    Pelletier G; Segond P; Attali P; Briantais MJ; Etienne JP
    Gastroenterol Clin Biol; 1984 Dec; 8(12):911-4. PubMed ID: 6394417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticardiolipin antibodies in patients with liver disease.
    Mangia A; Margaglione M; Cascavilla I; Gentile R; Cappucci G; Facciorusso D; Grandone E; Di Minno G; Rizzetto M; Andriulli A
    Am J Gastroenterol; 1999 Oct; 94(10):2983-7. PubMed ID: 10520856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
    Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
    Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of quantitative changes of the three classes of immunoglobulin in diseases of the liver].
    Mihara F
    Sapporo Igaku Zasshi; 1969 May; 35(5):320-42. PubMed ID: 4192667
    [No Abstract]   [Full Text] [Related]  

  • 39. [Incidence of delta antigen in various HBsAG-positive patients with liver diseases].
    Ternák G; László B; Gógl A; Nemes Z; Török A; Gál C; Szemes F; Bali I
    Orv Hetil; 1985 May; 126(18):1075-7. PubMed ID: 4000669
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of anti-tissue antibodies in the evolution of chronic liver diseases].
    Buligescu L; Moscaliuc I; Eşanu I; Ionică M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(6):445-52. PubMed ID: 6121363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.